VTE and Cancer: How to Talk to Your Patient
Upon completion of this activity, participants will:
- Have greater competence related to
- Application of latest evidence and recommendations into management of VTE in patients with cancer
Professor of Medicine
Cleveland Clinic Lerner College of Medicine
Professor of Medicine and Pathology
Division of Hematology
Johns Hopkins University School of Medicine
Participation by Dr Streiff does not constitute or imply endorsement by the Johns Hopkins University or the Johns Hopkins Hospital and Health System.
Vice Chair for Clinical Operations
Department of Medicine
Section of Cardiology
University of Chicago Medicine
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. This includes any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months, including financial relationships of a spouse or life partner that could create a conflict of interest. Mechanisms are in place to identify and resolve any potential conflict of interest prior to the start of the activity.
Additionally, The University of Chicago Pritzker School of Medicine requires authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Medscape designates this continuing education activity for 0.25 contact hour(s) (0.025 CEUs) (Universal Activity Number: JA0007105-0000-19-496-H01-P)